Found 6 matching trials
COMT Polymorphism and Entacapone Efficacy
PHASE4Entacapone is an antiparkinsonian drug which block L-dopa metabolism, inhib...
Location
Centre d'Investigation Clinique, Hôpital de la Pitié-Salpétrière,
Proof of Mechanism Study for the Treatment of Social Anhedonia in ASD
PHASE2This project will use the experimental medicine approach of a Phase IIa Pro...
Location
University of California, Los Angeles
Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia
PHASE2This is a double-blind, randomized, placebo-controlled Phase 2a study evalu...
Location
Sahlgrenska Hospital
Pivotal Study in Advanced Parkinsons Disease Patients
PHASE3The general aim of this trial is to determine the efficacy (as measured by ...
Location
248.525.43005 Boehringer Ingelheim Investigational Site
Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients
PHASE3The primary objective of this study was to demonstrate that Rotigotine tran...
A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period
PHASE2The objective of this trial is to investigate the safety, tolerability, tro...
Location
248.610.019 Boehringer Ingelheim Investigational Site